Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E W Ferguson

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Advances in Second Messenger and Phosphoprotein Research|January 1, 1992
Comparative studies on cyclic nucleotide phosphodiesterases and inhibitors in experimental models of hypertension, congestive heart failure, and allergic asthmaP J Silver, R J Gordon, R A Buchholz, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1989
Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pigA L Harris, M J Connell, E W Ferguson, et al.
Journal of Medicinal Chemistry|May 1, 1991
5-Lipoxygenase inhibitors: the synthesis and structure-activity relationships of a series of 1-phenyl-3-pyrazolidinonesD J Hlasta, F B Casey, E W Ferguson, et al.
The Journal of Surgical Research|June 1, 1996
Tissue factor pathway inhibitor protects the ischemic spinal cordB Koudsi, D M Chatman, B A Ballinger, et al.
Journal of Medicinal Chemistry|March 3, 1995
Orally bioavailable benzisothiazolone inhibitors of human leukocyte elastaseD J Hlasta, C Subramanyam, M R Bell, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Advances in Second Messenger and Phosphoprotein Research|January 1, 1992
Comparative studies on cyclic nucleotide phosphodiesterases and inhibitors in experimental models of hypertension, congestive heart failure, and allergic asthmaP J Silver, R J Gordon, R A Buchholz, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1989
Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pigA L Harris, M J Connell, E W Ferguson, et al.
Journal of Medicinal Chemistry|May 1, 1991
5-Lipoxygenase inhibitors: the synthesis and structure-activity relationships of a series of 1-phenyl-3-pyrazolidinonesD J Hlasta, F B Casey, E W Ferguson, et al.
The Journal of Surgical Research|June 1, 1996
Tissue factor pathway inhibitor protects the ischemic spinal cordB Koudsi, D M Chatman, B A Ballinger, et al.
Journal of Medicinal Chemistry|March 3, 1995
Orally bioavailable benzisothiazolone inhibitors of human leukocyte elastaseD J Hlasta, C Subramanyam, M R Bell, et al.
Pageof 4